Monoclonal Mouse anti‑Human Melanocyte Cell Surface Antigen Antibody (Biotin, IHC, IF) LS‑C527860
Monoclonal Mouse anti‑Human Melanocyte Cell Surface Antigen Antibody (Biotin, IHC, IF) LS‑C527860
Antibody:
Melanocyte Cell Surface Antigen Mouse anti-Human Monoclonal (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
Melanocyte Cell Surface Antigen Mouse anti-Human Monoclonal (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
Melanocyte Cell Surface Antigen antibody LS-C527860 is a biotin-conjugated mouse monoclonal antibody to human Melanocyte Cell Surface Antigen. Validated for IF and IHC.
Target
Human Melanocyte Cell Surface Antigen
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Biotin.
Also available
Unconjugated or conjugated with
FITC,
HRP,
PE.
Purification
Protein A purified
Immunogen
Human KW-mel(2.1) melanoma cells.
Specificity
Recognizes human MELANOCYTE CELL SURFACE ANTIGEN.
Applications
- IHC
- Immunofluorescence
- Applications tested for the base form of this product only
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles. Store undiluted.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
ELISA
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Human
Range:
1.6-1000 pg/ml
Reactivity:
Porcine
Range:
0.63-40 ng/ml
Reactivity:
Hamster
Range:
3.125-200 pg/ml
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/19/2024